CJC-1295 (No DAC) + Ipamorelin – Research Peptide Blend

Product Overview

CJC-1295 (No DAC) + Ipamorelin is a highly studied peptide combination designed for research into growth hormone–related pathways, cellular signaling, and recovery science. This blend pairs a Growth Hormone Releasing Hormone (GHRH) analog with a selective Growth Hormone Releasing Peptide (GHRP), offering a dual-action approach researchers utilize to explore synergistic effects on GH secretion.

This product is manufactured to high purity standards, providing dependable results for laboratory and in-vitro experimentation.

Key Features

• Synergistic Peptide Pair
  Combines CJC-1295 (No DAC), known for its short-acting GHRH analog profile, with Ipamorelin, a selective GHRP widely examined for its receptor specificity.

• High Purity for Reliable Results
  Each batch is third-party tested for identity, purity, and structural integrity to ensure consistent lab performance.

• Ideal for Growth Hormone Pathway Research
  Frequently used in studies focused on GH pulsatility, cellular regeneration models, sleep-related recovery mechanisms, and signaling pathways.

• Stable Lyophilized Format
  Convenient and stable for controlled laboratory environments.

Potential Research Applications

(For laboratory and scientific research use only)
Studies typically investigate this blend’s potential in:

• GH secretion pathway models

• Cellular repair and regeneration signaling

• Tissue-recovery mechanisms

• Sleep-related and circadian rhythm research

• Peptide-based anti-aging science

Specifications

• Peptide Blend: CJC-1295 (No DAC) + Ipamorelin

• Form: Lyophilized peptide powder

• Purity: High-performance liquid chromatography (HPLC) tested

• Use: For in-vitro and laboratory research only

• Storage: Keep in a cool, dry location; refrigerate after reconstitution if applicable

Important Notice

This product is NOT intended for human or animal consumption.
For laboratory research use only.
Not for diagnostic or therapeutic purposes.